Gilead to Market Truvada as PrEP
This 2012 photo shows Dr. Lisa Sterman who prescribed the drug off-label for about a dozen patients at high risk for developing AIDS.
Gilead's has had an FDA go-ahead since 2012 to market HIV medication Truvada (aka PrEP) as a preventative for healthy people. But the company has only just started to market it that way.
December 06 2016 7:30 AM EST
July 29 2021 10:08 PM EST